Abstract
This chapter summarizes the current knowledge about fecal microbiota transplantation (FMT) as a way to treat persistent diarrhea. Although this is an old concept, originated in China at least a millennium ago, it also represents a novel approach and an alternative to the use of antibiotics. This approach is a major departure from Paul Ehrlich´s old paradigm ‘the magic bullet,’ or a compound that supplied in a ‘dossa sterilisa magna’ would eliminate the parasite protozoan or bacterium, and represents a more ecological perspective in the fight against pathogenic microorganisms. This chapter includes additional topics, such as the effect of probiotics and ADP-ribosylation, as well as cAMP, cGMP, and phosphatidylinositol signaling. We also deal here with the problems associated with fecal transplant therapies when using human stool donors that, although asymptomatic, are in fact carriers of bacterial or parasite diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abd H, Johansson T, Golovliov I, Sandström G, Forsman M (2003) Survival and growth of Francisella tularensis in Acanthamoeba castellanii. Appl Environ Microbiol 69:600–606
Adamu BO, Lawley TD (2013) Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection. Curr Opin Microbiol 16:596–601
Al Kassaa I, Hober D, Hamze M, Chihib NE, Drider D (2014) Antiviral potential of lactic acid bacteria and their bacteriocins. Probiotics Antimicrob Proteins 6(3–4):177–185
Allen BW (1989) Isolation of Mycobacterium tuberculosis from faeces. Med Lab Sci 46:101–116
Alonso-Hearn M, Molina E, Geijo M, Vazquez P, Sevilla I, Garrido JM, Juste RA (2009) Isolation of Mycobacterium avium subsp. paratuberculosis from muscle tissue of naturally infected cattle. Foodborne Pathog 6:513–518
Ahmad I, Lamprokostopoulou A, Le Guyon S, Streck E, Barthel M, Peters V, Hardt WD, Römling U (2011) Complex c-di-GMP signaling networks mediate transition between virulence properties and biofilm formation in Salmonella enterica serovar typhimurium. PLoS ONE 6(12):e28351
Amarasinghe JJ, D’Hondt RE, Waters CM, Mantis NJ (2013) Exposure of Salmonella enterica Serovar typhimurium to a protective monoclonal IgA triggers exopolysaccharide production via a diguanylate cyclase-dependent pathway. Infect Immun 81:653–664
Ameglio F, Abbolito MR, Giannarelli D, Citarda F, Grassi A, Gandolfo GM, Casale V (1991) Detection of Helicobacter pylori carriers by discriminant analysis of urea and pH levels in gastric juices. J Clin Pathol 44:697–698
Anacker RL, Ordal EJ (1959) Studies on the myxobacterium Chondrococcus columnaris. II. Bacteriocins. J Bacteriol 78:33–40
Ananthaswamy A (2011) Faecal transplant eases symptoms of Parkinson’s. New Scientist. Retrieved 22 Jan 2013
Anderson MT, Seifert HS (2011) Opportunity and means: horizontal gene transfer from the human host to a bacterial pathogen. mBio 2(1):e00005–e00011
Anderson JL, Edney RJ, Whelan K (2012) Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 36:503–516
Armuzzi A, Cremonini F, Bartolozzi F, Canducci F, Candelli M, Ojetti V, Cammarota G, Anti M, De Lorenzo A, Pola P, Gasbarrini G, Gasbarrini A (2001) The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 15:163–169
Arnold IC, Hitzler I, Müller A (2012) The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders. Front Cell Infect Microbiol 2:10
Arvola T, Laiho K, Torkkeli S, Mykkänen H, Salminen S, Maunula L, Isolauri E (1999) Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 104:e64
Auger KR, Serunian LA, Soltoff SP, Libby P, Cantley LC (1989) PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57:167–175
Bacon AE, Fekety R, Schaberg DR, Faix RG (1988) Epidemiology of Clostridium difficile colonization in newborns: results using a bacteriophage and bacteriocin typing system. J Infect Dis 158:349–354
Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, Kelly C, Khoruts A, Louie T, Martinelli LP, Moore TA, Russell G, Surawicz C (2011) Treating Clostridium difficile Infection With Fecal Microbiota Transplantation. Clinical Gastroenter and Hepatol 9:1044–1049
Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E, Graziani A (2002) Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 159:1029–1037
Balli F, Bertolani P, Giberti G, Amarri S (1992) High-dose oral bacteria-therapy for chronic non-specific diarrhea of infancy. Pediatr Med Chir v 14:13–15
Bari SM, Roky MK, Mohiuddin M, Kamruzzaman M, Mekalanos JJ, Faruque SM (2013) Quorum-sensing autoinducers resuscitate dormant Vibrio cholerae in environmental water samples. Proc Natl Acad Sci USA 110:9926–9931
Barker J, Brown MR (1994) Trojan horses of the microbial world: protozoa and the survival of bacterial pathogens in the environment. Microbiology 140:1253–1259
Barrett KE, Keely SJ (2000) Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Annu Rev Physiol 62:535–572
Barua D, Cvjetanovic B (1972) The seventh pandemic of cholera. Nature 239:137–138
Basu N, Saha S, Khan I, Ramachandra SG, Visweswariah SS (2014) Intestinal cell proliferation and senescence are regulated by receptor guanylyl cyclase C and p21. J Biol Chem 289:581–593
Bazzocchi G, Gionchetti P, Almerigi PF, Amadini C, Campieri M (2002) Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome. Dig Liver Dis 2:S48–S53
Bharati K, Ganguly NK (2011) Cholera toxin: a paradigm of a multifunctional protein. Indian J Med Res 133:179–187
Beausoleil M, Fortier N, Guénette S, L’ecuyer A, Savoie M, Franco M, Lachaine J, Weiss K (2007) Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol 21:732–736
Ben-Gurion R, Hertman I (1958) Bacteriocin-like material produced by Pasteurella pestis. J Gen Microbiol 19:289–297
Berger F, Ramírez-Hernández MH, Ziegler M (2004) The new life of a centenarian: signalling functions of NAD(P). Trends Biochem Sci 29:111–118
Berridge NJ (1949) Preparation of the antibiotic nisin. Biochem J 45:486–493
Beutin L (2006) Emerging enterohaemorrhagic Escherichia coli, causes and effects of the rise of a human pathogen. J Vet Med B Infect Dis Vet Public Health 53:299–305
Blecker U, Lanciers S, Hauser B, Vandenplas Y (1994) The prevalence of Helicobacter pylori positivity in a symptom-free population, aged 1 to 40 years. J Clin Epidemiol 47:1095–1098
Bodian D, Horstmann DH (1965) Polioviruses. In: Horsfall FL, Tamm I (eds) Viral and Rickettsial Infections of Man. Lippincott, Philadelphia, pp 430–473
Borody TJ (2000) “Flora Power”– fecal bacteria cure chronic C. difficile diarrhea. Am J Gastroenterol 95:3028–3029
Borody TJ, Warren EF, Leis S, Surace R, Ashman O (2003) Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 37:42–47
Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas S (2004) Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol 38:475–483
Borody TJ, Paramsothy S, Agrawal G (2013) Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep 15:337–344
Bowden TA, Mansberger AR, Lykins LE (1981) Pseudomembranous enterocolitis: mechanism of restoring floral homeostasis. Am Surg 47:178–183
Brock TD, Peacher B, Pierson D (1963) Survey of the bacteriocines of enterococci. J Bacteriol 86:702–707
Bronze MS, Greenfield RA (eds) (2005) Biodefence principles and pathogens horizon. Bioscience, United Kingdom
Brown NL, Misra TK, Winnie JN, Schmidt A, Seiff M, Silver S (1986) The nucleotide sequence of the mercuric resistance operons of plasmid R100 and transposon Tn501: further evidence for mer genes which enhance the activity of the mercuric ion detoxification system. Mol Gen Genet 202:143–151
Bryant MP (1974) Nutritional features and ecology of predominant anaerobic bacteria of the intestinal tract. Am J Clin Nutr 27:1313–1319
Burke JD, Platanias LC, Fish EN (2014) Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3. J Virol 88:3485–3495
Camorlinga M, Muñoz O, Guiscafré H, Torres J (1991) Colonization by Clostridium difficile in hospitalized children: risk factors and typification of the isolated strains. Arch Invest Med (Mex) 22:19–26
Caruso ML, Fucci L (1990) Histological identification of Helicobacter pylori in early and advanced gastric cancer. J Clin Gastroenterol 12:601–602
Cassoni P, Ghé C, Marrocco T, Tarabra E, Allia E, Catapano F, Deghenghi R, Ghigo E, Papottiand M, Muccioli G (2004) Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol 150:173–184
Castellani A, Chalmers AJ (1919) The dysenteries. In: Manual of tropical medicine. William Wood & Co., New York
Chae KS, Yoo OJ (1986) Cloning of the lambda resistant genes from Brevibacterium albidum and Proteus vulgaris into Escherichia coli. Biochem Biophys Res Commun 140:1101–1105
Champigny G, Verrier B, Lazdunski M (1991) A voltage, calcium, and ATP sensitive nonselective cation channel in human colonic tumor cells. Biochem Biophys Res Commun 176:1196–1203
Chaudhuri AG, Sen PC, Ganguly U (1993) Evidence for protein kinase C stimulation in rat enterocytes pretreated with heat stable enterotoxin of Escherichia coli. FEMS Microbiol Lett 110:185–189
Chen LC, Rohde JE, Sharp GW (1971) Intestinal adenyl-cyclase activity in human cholera. Lancet 1(7706):939–941
Chi C, Sun Q, Wang S, Zhang Z, Li X, Cardona CJ, Jin Y, Xing Z (2013) Robust antiviral responses to enterovirus 71 infection in human intestinal epithelial cells. Virus Res 176:53–60
Chung DW, Collier RJ (1977a) The mechanism of ADP-ribosylation of elongation factor 2 catalyzed by fragment A from diphtheria toxin. Biochim Biophys Acta 483:248–257
Chung DW, Collier RJ (1977b) Enzymatically active peptide from the adenosine diphosphate-ribosylating toxin of Pseudomonas aeruginosa. Infect Immun 16:832–841
Collado MC, Hernández M, Sanz Y (2005) Production of bacteriocin-like inhibitory compounds by human fecal Bifidobacterium strains. J Food Prot 68:1034–1040
Collins MT (1997) Mycobacterium paratuberculosis: a potential food-borne pathogen? J Dairy Sci 80:3445–3448
Cooke G, Behan J, Costello M (2006) Newly identified vitamin K-producing bacteria isolated from the neonatal faecal flora. Microbial Ecology in Health and Disease 18:133–138
Connell WT (1911) Human carriers of disease. Can Med Assoc J 4:325–334
Corda D, Di Girolamo M (2003) Functional aspects of protein mono-ADP-ribosylation. EMBO J 22(9):1953–1958
Corrigan RM, Gründling A (2013) Cyclic di-AMP: another second messenger enters the fray. Nat Rev Microbiol 11:513–524
Cossart P, Boquet P, Normark S, Rappuoli R (1996) Cellular microbiology emerging. Science 271:315–316
Cotter PA, Stibitz S (2007) c-di-GMP-mediated regulation of virulence and biofilm formation. Curr Opin Microbiol 10:17–23
Cox SS, van der Giezen M, Tarr SJ, Crompton MR, Tovar J (2006) Evidence from bioinformatics, expression and inhibition studies of phosphoinositide-3 kinase signalling in Giardia intestinalis. BMC Microbiol 6:45
Crump JA, Bopp CA, Greene KD, Kubota KA, Middendorf RL, Wells JC, Mintz E (2003) Toxigenic Vibrio cholerae serogroup O141-associated cholera-like diarrhea and bloodstream infection in the United States. J Infect Dis 187:866–868
Cummins (1910) Br Med J 2:440
Cuzzolin L, Zambreri D, Donini M, Griso C, Benoni G (1992) Influence of radiotherapy on intestinal microflora in cancer patients. J Chemother 4:176–179
Dalhoff A (1982) Influence of Escherichia coli on Streptococcus faecalis in mixed cultures and experimental animal infections. Eur J Clin Microbiol 1:17–21
Datta A, Prescott LM (1969) Bacteriocin production by Vibrio cholerae. I. Effects of vibriocins on Vibrio cholerae. Ind J Med Res 57:1402–1408
Davies BW, Bogard RW, Young TS, Mekalanos JJ (2012) Coordinated regulation of accessory genetic elements produces cyclic di-nucleotides for V. cholerae virulence. Cell 149:358–370
Dharmsathaphorn K (1985) Intestinal somatostatin function. Adv Exp Med Biol 188:463–473
Dharmsathaphorn K, Huott PA, Vongkovit P, Beuerlein G, Pandol SJ, Ammon HV (1989) Cl- secretion induced by bile salts. A study of the mechanism of action based on a cultured colonic epithelial cell line. J Clin Invest 84:945–953
De SN (1959) Enterotoxicity of bacteria-free culture filtrate of Vibrio cholerae. Nature 183:1533–1534
De Haan L, Hirst TR (2004) Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms. Mol Membr Biol 21:77–92
de Jonge HR (1981) Cyclic GMP-dependent protein kinase in intestinal brushborders. Adv Cyclic Nucleotide Res 14:315–333
de Jonge HR (1984) Cyclic nucleotide-dependent protein phosphorylation in intestinal epithelium. Kroc Found Ser 17:263–286
de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL (1998) Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474–477
Derbyshire ER, Marletta MA (2009) Biochemistry of soluble guanylate cyclase. Handb Exp Pharmacol 191:17–31
Dey AK, Bhagat A, Chowdhury R (2013) Host cell contact induces expression of virulence factors and VieA, a cyclic di-GMP phosphodiesterase, in Vibrio cholerae. J Bacteriol 195:2004–2010
Domínguez P, Velasco G, Barros F, Lazo PS (1987) Intestinal brush border membranes contain regulatory subunits of adenylyl cyclase. Proc Natl Acad Sci USA 84:6965–6969
D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ (2002) Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324(7350):1361
Dubos RJ, Schaedler RW (1960) The effect of the intestinal flora on the growth rate of mice, and on their susceptibility to experimental infections. J Exp Med 111:407–417
Dubos RJ, Schaedler RW, Costello R (1963) Composition, alteration, and effects of the intestinal flora. Fed Proc 22:1322–1329
Dubos RJ, Schaedler RW, Costello R, Hoet P (1965) Indigenous, normal, and autochthonous flora of the gastrointestinal tract. J Exp Med 122:67–76
Eguchi S, Takatsuki M, Hidaka M, Soyama A, Ichikawa T, Kanematsu T (2011) Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. Am J Surg 201:498–502
Eiseman B, Silen W, Bascom GS, Kauvar AJ (1958) Fecal enema as an adjunct in the treatment ofPseudomembranous enterocolitis. Surgery 44:854–859
Ellison JS, Kautter JA (1970) Purification and some properties of two boticins. J Bacteriol 104:19–26
Ewe K, Wanitschke R (1977) Current concepts in the pathophysiology of the diarrhea (author’s transl). Leber Magen Darm 7(1):1–2
Falcão DP, Mendonça CP, Scrassolo A, De Almeidaa BB, Hart L, Farmer H, Farmer JJ III (1972) Nursery outbreak of severe diarrhoea due to multiple strains of Pseudomonas æruginosa. The Lancet 300:38–40
Famularo G, Mosca L, Minisola G, Trinchieri V, De Simone C (2003) Probiotic lactobacilli: a new perspective for the treatment of inflammatory bowel disease. Curr Pharm Des 9:1973–1980
Fatima M, Rempel H, Kuang XT, Allen KJ, Cheng KM, Malouin F, Diarra MS (2013) Effect of 3′, 5′-cyclic diguanylic acid in a broiler Clostridium perfringens infection model. Poult Sci 92:2644–2650
Fiskerstrand T, Arshad N, Haukanes BI, Tronstad RR, Pham KD, Johansson S, Håvik B, Tønder SL, Levy SE, Brackman D, Boman H, Biswas KH, Apold J, Hovdenak N, Visweswariah SS, Knappskog PM (2012) Familial diarrhea syndrome caused by an activating GUCY2C mutation. N Engl J Med 366:1586–1595
Flanagan P, Campbell BJ, Rhodes JM (2011) Bacteria in the pathogenesis of inflammatory bowel disease. Biochem Soc Trans 39:1067–1072
Flores CA, Melvin JE, Figueroa CD, Sepúlveda FV (2007) Abolition of Ca2+-mediated intestinal anion secretion and increased stool dehydration in mice lacking the intermediate conductance Ca++-dependent K+ channel Kcnn4. J Physiol 583:705–717
Foster JW, Woodruff HB (1946) Bacillin, a new antibiotic substance from a soil isolate of Bacillus subtilis. J Bacteriol 51:363–369
Frédéricq P (1957) Colicins. Ann Rev Microbiol 11:7–22
Friedman D, Court D (2001) Bacteriophage lambda: alive and well and still doing its thing. Curr Opin Microbiol 4:201–207
Galloway TS, van Heyningen S (1987) Binding of NAD + by cholera toxin. Biochem J 244:225–230
Gangarosa EJ, Saghari H, Emile J, Siadat H (1966) Detection of Vibrio cholerae biotype El Tor by Purging. Bull Wld Hlth Org 34:363–369
Gerding DN, Johnson S, Rupnik M, Aktories K (2014) Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes 5:15–27
Ghè C, Cassoni P, Catapano F, Marrocco T, Deghenghi R, Ghigo E, Muccioli G, Papotti M (2002) The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology 143:484–491
Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M, Campieri M (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119:305–309
Goor RS, Maxwell ES (1969) A proposed mechanism for ADP ribosylation of aminoacyl transferase II by diphtheria toxin. Cold Spring Harb Symp Quant Biol 34:609–610
Gotschlich F (1905) Vibrions cholériques isolés au campement de Tor. Retour du pèlerinagede l’année 1905. Rapport adresse au président du Conseil quarantenaire d’Egypte, Alexandrie. Bulletin Institut Pasteur 3:726
Granata R, Settanni F, Trovato L, Destefanis S, Gallo D, Martinetti M, Ghigo E, Muccioli G (2006) Unacylated as well as acylated ghrelin promotes cell survival and inhibit apoptosis in HIT-T15 pancreatic β-cells. J Endocrinol Invest 29:19–22
Grant AK, Purser BN, Hazel JR (1969) Shigella flexneri dysentery in the Australian forces in South Vietnam. Med J Aust 2:752–755
Grehan MJ, Borody TJ, Leis SM, Campbell J, Mitchell H, Wettstein A (2010) Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 44:551–561
Gülke I, Pfeifer G, Liese J, Fritz M, Hofmann F, Aktories K, Barth H (2001) Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile. Infect Immun 69:6004–6011
Hall FA (1971) Bacteriocin typing of Klebsiella spp. J Clin Path 24:712–716
Halpern M, Landsberg O, Raats D, Rosenberg E (2007) Culturable and VBNC Vibrio cholerae: interactions with chironomid egg masses and their bacterial population. Microb Ecol 53:285–293
Hamon Y (1956) Contribution A l’etude des pyocines. Ann Inst Pasteur 91:82–90
Hamon Y, Péron Y (1961) Les proprietesantagonistes reciproques parmiles Erwinia. Discussion de la positiontaxonomique de ce genre. Compt Ren. 253:913–915
Hamon Y, Péron Y (1962) Etude dupouvoir bacteriocinoge’ne dans le genre Listeria. I. Proprietes generales de cesbactdriocines. Ann Inst Pasteur 103:876–889
Hamon Y, Péron Y (1963a) Individualisation de quelques nouvelles familles d’enterobacteriocines. Compt Rend 257:309–311
Hamon Y, Péron Y (1963b) Quelques remarques sur les bacteriocines produites par les microbes gram-positifs. Compt Rend 257:1191–1193
Hamon Y, Veron M, Péron Y (1961) Contribution a l’étude des proprietes lysogenes et bactériocinogenes dans le genre Pseudomonas. Ann. Inst. Pasteur 101:738-753
Hansen J, Gulati A, Sartor RB (2010) The role of mucosal immunity and host genetics in defining intestinal commensal bacteria. Curr Opin Gastroenterol 26:564–571
Helin T, Haahtela S, Haahtela T (2002) No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 57:243–246
Holt RJ, Newman RL (1967) Candida in the faeces of children receiving oral tetracycline and phenoxymethyl penicillin. J Clin Pathol 20:80–83
Horst H, Kohlhase B (1986) Asymptomatic excretors of rotavirus. Infection 14:163–166
Hossain MA, Hasan KZ, Albert MJ (1994) Shigella carriers among non-diarrhoeal children in an endemic area of shigellosis in Bangladesh. Trop Geogr Med 46:40–42
Hu J, Wang B, Fang X, Means WJ, McCormick RJ, Gomelsky M, Zhu MJ (2013) c-di-GMP signaling regulates E. coli O157:H7 adhesion to colonic epithelium. Vet Microbiol 164:344–351
Hulse EC, Lancaster JE (1951) The treatment with nisin of chronic bovine mastitis caused by Str. uberis and staphylococci. Vet Rec 63:477–480
Hyams JS (2000) Inflammatory bowel disease. Pediatr Rev 21:291–295
Huckstep RL (1962) The carrier and its treatment. In: Typhoid fever and other Salmonella infections. Livingston, Edinburgh, pp 231–241
Imirzalioglu C, Dahmen H, Hain T, Billion A, Kuenne C, Chakraborty T, Domann E (2011) Highly specific and quick detection of Mycobacterium avium subsp. paratuberculosis in feces and gut tissue of cattle and humans by multiple real-time PCR assays. J Clin Microbiol 49:1843–1852
Inada T, Kimata K, Aiba H (1996) Mechanism responsible for glucose–lactose diauxie in Escherichia coli: challenge to the cAMP model. Genes Cells 1:293–301
Isolauri E, Kaila M, Mykkänen H, Ling WH, Salminen S (1994) Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci 39:2595–2600
Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S (2001) Probiotics: effects on immunity. Am J Clin Nutr 73:444S–450S
Israil AM, Nacescu N, Ciufecu C, Stefanescu C (1983) Studies on bacteriocin production by NAG-strains of Vibrio cholerae as a possible epidemiological marker. Zentralbl Bakteriol Mikrobiol Hyg A 255:285–293
Ivanovics G, Nagy E (1958) Hereditary aberrancy in growth of some Bacillus megaterium strains. J Gen Microbiol 19:407–418
Ivanovics G (1962) Bacteriocins and bacteriocin-like substances. Bacteriol Rev 26:108–118
Jacob F, Lwoff A, Siminovirch A, Wollman P (1953) D6finition de quelquestermes relatifs a la lysogenie. Ann inst Pasteur 84:222–224
Jones MK, Tomikawa M, Mohajer B, Tarnawski AS (1999) Gastrointestinal mucosal regeneration: role of growth factors. Front Biosci 4:D303–D309
Kansal R, Rasko DA, Sahl JW, Munson GP, Roy K, Luo Q, Sheikh A, Kuhne KJ, Fleckenstein JM (2013) Transcriptional modulation of enterotoxigenic Escherichia coli virulence genes in response to epithelial cell interactions. Infect Immun 81:259–270
Katzung BG (2007) Basic and clinical pharmacology, 9th edn. McGraw Hill Medical, New York, p 733
Kawai Y, Ishii Y, Arakawa K, Uemura K, Saitoh B, Nishimura J, Kitazawa H, Yamazaki Y, Tateno Y, Itoh T, Saito T (2004) Structural and functional differences in two cyclic bacteriocins with the same sequences produced by lactobacilli. Appl Environ Microbiol 70:2906–2911
Kayser ADK (1906) Gesundheitsamte, Bd. 24, p. 176
Kelly CP, LaMont JT (2008) Clostridium difficile: more difficult than ever. N Engl J Med 359:1932–1940
Kelstrup J, Gibbons RJ (1969) Inactivation of bacteriocins in the intestinal canal and oral cavity. J Bacteriol 99:888–890
Kerekes L (1968) Virulence of Shigella strains isolated from dysenteric patients and symptomless carriers. Acta Microbiol Acad Sci Hung 15:361–367
Khoruts A, Dicksved J, Jansson JK, Sadowsky M (2010) Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 44:354–360
Kingsbury DT (1966) Bacteriocin production by strains of Neisseria meningitidis. J Bacteriol 91:1696–1699
Kirjavainen PV, Gibson GR (1999) Healthy gut microflora and allergy: factors influencing development of the microbiota. Ann Med 31:288–292
Koch R (1884) An address on cholera and its bacillus. Dtsch Med Wochenschr 10:111 (English translation in Br Med J ii:403–407, 453–459)
Koch J, Korbmacher C (1999) Osmotic shrinkage activates nonselective cation (NSC) channels in various cell types. J Membr Biol 168:131–139
Koestler BJ, Waters CM (2014) Bile Acids Regulate Intracellular Cyclic di-GMP in Vibrio cholerae. Infect Immun 82:3002–3014
Krasteva PV, Fong JC, Shikuma NJ, Beyhan S, Navarro MV, Yildiz FH, Sondermann H (2010) Vibrio cholerae VpsT regulates matrix production and motility by directly sensing cyclic di-GMP. Science 327:866–868
Kumamoto CA (2011) Inflammation and gastrointestinal Candida colonization. Curr Opin Microbiol 14:386–391
Kunzelmann K, Mall M (2002) Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev 82:245–289
Kusnetsov J, Iivanainen E, Elomaa N, Zacheus O, Martikainen PJ (2001) Copper and silver ions more effective against legionellae than against mycobacteria in a hospital warm water system. Water Res 35:4217–4225
Kwaik AY (1996) The phagosome containing Legionella pneumophila within the protozoan Hartmanella vermiformis is surrounded by the rough endoplasmic reticulum. Appl Environ Microbiol 62:2022–2028
Lee JH, Karamychev VN, Kozyavkin SA, Mills D, Pavlov AR, Pavlova NV, Polouchine NN, Richardson PM, Shakhova VV, Slesarev AI, Weimer B, O’Sullivan DJ (2008) Comparative genome analysis of the gut bacterium Bifidobacterium longum reveals loci susceptible to deletion during pure culture growth. BMC Genom 9:247
Lencer WI (2001) Microbes and microbial toxins: paradigms for microbial-mucosal toxins. V. Cholera: invasion of the intestinal epithelial barrier by a stably folded protein toxin. Am J Physiol Gastrointest Liver Physiol 280:G781–G786
Levine MM, Hornick RB (1975) Lactulose therapy in Shigella carrier state and acute dysentery. Antimicrob Agents Chemother 8:581–584
Lewis SJ, Potts LF, Barry RE (1998) The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. J Infect 36:171–174
Li YP, Vegge CS, Brøndsted L, Madsen M, Ingmer H, Bang DD (2011) Campylobacter jejuni induces an anti-inflammatory response in human intestinal epithelial cells through activation of phosphatidylinositol 3-kinase/Akt pathway. Vet Microbiol 148:75–83
Loffeld RJ, Willems I, Flendrig JA, Arends JW (1990) Helicobacter pylori and gastric carcinoma. Histopathology 17:537–541
Lu L, Khan A, Walker WA (2009) ADP-ribosylation factors regulate the development of CT signaling in immature human enterocytes. Am J Physiol Gastrointest Liver Physiol 296:G1221–G1229
Macpherson AJ, Uhr T (2004) Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303:1662–1665
Mahony DE, Swantee CA (1978) Bacteriocin typing of Clostridium perfringens in human feces. J Clin Microbiol 7:307–309
Maxwell ES, Robinson EA, Henriksen O (1975) Proceedings: Elongation factor 2: amino acid sequence at the site of ADP-ribosylation. J Biochem 77:9p-b
Mazza P (1994) The use of Bacillus subtilis as an antidiarrhoeal microorganism. Dig Dis Sci 39:2595–2600
Mazzucchelli L, Wilder-Smith CH, Ruchti C, Meyer-Wyss B, Merki HS (1993) Gastrospirillum hominis in asymptomatic, healthy individuals. Dig Dis Sci 38:2087–2089
McDonough KA, Rodriguez A (2011) The myriad roles of cyclic AMP in microbial pathogens: from signal to sword. Nat Rev Microbiol 10:27–38
McKee RW, Mangalea MR, Purcell EB, Borchardt EK, Tamayo R (2013) The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD. J Bacteriol 195:5174–5185
Metchnikoff E (1907) Essais optimistes. Paris In: Chalmers Mitchell P(Translated and ed) The prolongation of life. Optimistic studies. Heinemann, London
Miller CE, Wong KH, Feeley JC, Forlines ME (1972) Immunological conversion of Vibrio cholerae in gnotobiotic mice. Infect Immun 6:739–742
Millette M, Cornut G, Dupont C, Shareck F, Archambault D, Lacroix M (2008) Capacity of human nisin- and pediocin-producing lactic acid bacteria to reduce intestinal colonization by vancomycin-resistant enterococci. Appl Environ Microbiol 74:1997–2003
Miranda CM, Farias LM, Carvalho MA, Damasceno CA, Totola AH, Tavares CA, Cisalpino EO, Vieira EC (1993) Purification and partial characterization of a bacteriocin isolated from Bacteroides ovatus H47. Can J Microbiol 39:169–174
Mital BK, Garg SK (1995) Anticarcinogenic, hypocholesterolemic, and antagonistic activities of Lactobacillus acidophilus. Crit Rev Microbiol 21:175–214
Mitchell I, Shropshire K, Ruel J (2013) Clostridium difficile infection and fecal bacteriotherapy. Gastroenterol Nurs 36:42–50
Molla A, Lonnroth I, Jahan F, Bardhan PK, Molla AM, Holmgren J (1985) Stool cyclic AMP in diarrhoea due to different causative organisms. J Diarrhoeal Dis Res 3:199–204
Molmeret M, Horn M, Wagner M, Santic M, Kwaik YA (2005) Amoebae as training grounds for intracellular bacterial pathogens. Appl Environ Microbiol 71:20–28
Moxon ER, Kroll JS (1990) The role of bacterial polysaccharide capsules as virulence factors. Curr Top Microbiol Immunol 150:65–85
Nakamura A (1967) Virulence of Shigella isolated from healthy carriers. Jpn J Med Sci Biol 20:213–223
Neer EJ, Murad F (1979) Separation of soluble adenylate and guanylate cyclases from the mature rat testis. Biochim Biophys Acta 583:531–534
Nicand E, Grandadam M, Teyssou R, Rey JL, Buisson Y (2001) Viraemia and faecal shedding of HEV in symptom-free carriers. The Lancet 357:68–69
Nomoto K (2008) Prevention of postoperative microbial infection by synbiotics. Indian J Exp Biol 46:557–561
Novak EA, Sultan SZ, Motaleb MdA (2014) The cyclic-di-GMP signaling pathway in the Lyme disease spirochete, Borrelia burgdorferi. Front Cell Infect Microbiol 4(56):1–11
Nucci M, Anaissie E (2001) Revisiting the source of candidemia: skin or gut? Clin Infect Dis 33:1959–1967
Okada K, Chantaroj S, Taniguchi T, Suzuki Y, Roobthaisong A, Puiprom O, Honda T, Sawanpanyalert P (2010) A rapid, simple, and sensitive loop-mediated isothermal amplification method to detect toxigenic Vibrio cholerae in rectal swab samples. Diagn Microbiol Infect Dis 66:135–139
Olsnes S, Reibig R, Eiklid K (1981) Subunit structure of Shigella cytotoxin. J Biol Chem 256:8732–8738
Osek J, Gallien P, Protz D (2000) Characterization of shiga toxin-producing Escherichia coli strains isolated from calves in Poland. Comp Immunol Microbiol Infect Dis 23:267–276
Pacini F (1854) Osservazioni microscopiche e deduzioni patologiche sul colera asiatico. Gazzetta Medica Italiana Federativa
Park JM, Kakimoto T, Kuroki T, Shiraishi R, Fujise T, Iwakiri R, Fujimoto K (2008) Suppression of intestinal mucosal apoptosis by ghrelin in fasting rats. Exp Biol Med 233:48–56
Paunescu TG, Ljubojevic M, Russo LM, Winter C, McLaughlin MM, Wagner CA, Breton S, Brown D (2010) cAMP stimulates apical V-ATPase accumulation, microvillar elongation, and proton extrusion in kidney collecting duct A-intercalated cells. Am J Physiol Renal Physiol 298:643–654
Perelle S, Gibert M, Bourlioux P, Corthier G, Popoff MR (1997) Production of a complete binary toxin (actinspecific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun 65:1402–1407
Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC, Brown EM, Schroeter K, Allen-Vercoe E (2013) Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut. Microbiome 1(3):1–12
Pierce NF, Banwell JG, Gorbach SL, Mitra RC, Mondal A (1970) Convalescent carriers of Vibrio cholerae: detection and detailed investigation. Ann Intern Med 72:357–364
Podolsky DK (1993) Regulation of intestinal epithelial proliferation: a few answers, many questions. Am J Physiol 264:179–186
Pollitzer R (1959) Cholera, Geneva. World Health Organization: Monograph Series No. 43, pp 491–495
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, MetaHIT Consortium, Bork P, Ehrlich SD, Wang J (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65
Rahman N, Buck J, Levin LR (2013) pH sensing via bicarbonate-regulated “soluble” adenylyl cyclase (sAC). Front Physiol 4:1–5
Ranganathan N, Patel BG, Ranganathan P, Marczely J, Dheer R, Pechenyak B, Dunn SR, Verstraete W, Decroos K, Mehta R, Friedman EA (2006) In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease. ASAIO J 2:70–79
Rea MC, Sit CS, Clayton E, O’Connor PM, Whittal RM, Zheng J, Vederas JC, Ross RP, Hill C (2010) Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci USA 107:9352–9357
Reeves P (1972) The bacteriocins in: molecular biology, biochemistry and biophysics, vol 11. Springer, Berlin
Reid G, Jass J, Sebulsky MT, McCormick JK (2003) Potential uses of probiotics in clinical practice. Clin Microbiol Rev 16:658–672
Ribner BS, Freimer EH (1978) Oxolinic acid for the treatment of chronic gastrointestinal Shigella carriers. Am J Trop Med Hyg 27:840–842
Rijkers GT, Bengmark S, Enck P, Haller D, Herz U, Kalliomaki M, Kudo S, Lenoir-Wijnkoop I, Mercenier A, Myllyluoma E, Rabot S, Rafter J, Szajewska H, Watzl B, Wells J, Wolvers D, Antoine JM (2010) Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr 140:671S–676S
Rohrer H, Zillig W, Mailhammer R (1975) ADP-ribosylation of DNA-dependent RNA polymerase of Escherichia coli by an NAD+: protein ADP-ribosyltransferase from bacteriophage T4. Eur J Biochem 60:227–238
Romi H, Cohen I, Landau D, Alkrinawi S, Yerushalmi B, Hershkovitz R, Newman-Heiman N, Cutting GR, Ofir R, Sivan S, Birk OS (2012) Meconium ileus caused by mutations in GUCY2C, encoding the CFTR-activating guanylate cyclase 2C. Am J Hum Genet 90:893–899
Rosenbach A, Dignard D, Pierce JV, Whiteway M, Kumamoto CA (2010) Adaptations of Candida albicans for growth in the mammalian intestinal tract. Eukaryot Cell 9:1075–1086
Ross P, Weinhouse H, Aloni Y, Michaeli D, Weinberger-Ohana P, Mayer R, Braun S, de Vroom E, van der Marel GA, van Boom JH, Benziman M (1987) Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid. Nature 325:279–281
Russell G, Kaplan J, Ferraro M, Michelow IC (2010) Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol. Pediatrics 126:e239–e242
Ruth P (1999) Cyclic GMP-dependent protein kinases: understanding in vivo functions by gene targeting. Pharmacol Ther 82:355–372
Ryan KJ, Ray CG (2004) Sherris medical microbiology: an introduction to infectious disease, 4th ed. McGraw-Hill, New York
Sack DA, Sack RB, Nair GB, Siddique AK (2004) Cholera. Lancet 363(9404):223–233
Sakurai K, Chen J, Kefalov V (2011) Role of guanylyl cylcase modulation in mouse cone phototransduction. J Neurosci 22:7991–8000
Salle AJ, Jann GJ (1945) Subtilin, an antibiotic produced by Bacillus subtilis; action on various organisms. Proc Soc Exp Biol Med 60:60–64
Salle AJ, Jann GJ (1946) Effect of subtilin on the course of experimental anthrax infections in guinea pigs. Proc Soc Exp Biol Med 63:41
Sanders ME (2000) Considerations for use of probiotic bacteria to modulate human health. J Nutrition 130:384S–390S
Savage DC (1977) Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31:107–133
Schaedler RW, Dubos R, Costello R (1965) The development of the bacterial flora in the gastrointestinal tract of mice. J Exp Med 122:59–66
Seksik P, Rigottier-Gios L, Gramet G, Sutren M, Pochart P, Marteau P, Jian R, Dore J (2003) Alterations of the dominant faecal bacterial groups in patients with Crohn’s disease of the Colon. Gut 57:237–242
Senior BW (1977) Typing of Proteus strains by proticin production and sensitivity. J Med Microbiol 10:7–17
Senior BW (1987) The typing of Morganella morgani by bacteriocin production and sensitivity. J Med Microbiol 23:33–39
Schiutze K, Hentschel E, Dragosics B, Hirschl AM (1995) Helicobacter pylori reinfection with identical organisms: transmission by the patients’ spouses. Gut 36:831–833
Shafer WM, Ohnecka EA (2011) Taking the gonococcus-human relationship to a whole new level: implications for the coevolution of microbes and humans. mBio 2:e00067-11
Shahinas D, Silverman M, Sittler T, Chiu Ch, Kim P, Allen-Vercoe E, Weese S, Wong A, Low DE, Pillaij DR (2012) Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. mbio 3(5) pii: e00338-12
Shandera WX, Hafkin B, Martin DL, Taylor JP, Maserang DL, Wells JG, Kelly M, Ghandi K, Kaper JB, Lee JV, Blake PA (1983) Persistence of cholera in the United States. Am J Trop Med Hyg 32:812–817
Sheng H, Shao J, Townsend CM Jr, Evers BM (2003) Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells. Gut 52:1472–1478
Sigman M, Luchette FA (2012) Cholera: something old, something new. Surg Infect (Larchmt) 13:216–222
Silos-Santiago I, Hannig G, Eutamene H, Ustinova EE, Bernier SG, Ge P, Graul C, Jacobson S, Jin H, Liong E, Kessler MM, Reza T, Rivers S, Shea C, Tchernychev B, Bryant AP, Kurtz CB, Bueno L, Pezzone MA, Currie MG (2013) Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation. Pain 154:1820–1830
Silva SH, Vieira EC, Dias RS, Nicoli JR (2001) Antagonism against Vibrio cholerae by diffusible substances produced by bacterial components of the human faecal microbiota. J Med Microbiol 50:161–164
Shiga K (1898) Ueber den Erreger der Dysenterie in Japan. Vorläufige Mitteilung. Zentralbl Bakteriol Microbiol Hyg 23:599–600
Soll DR, Galask R, Schmid J, Hanna C, Mac K, Morrow B (1991) Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J Clin Microbiol 29:1702–1710
Songyang Z, Blechner S, Hoagland N, Hoekstra MF, Piwnica-Worms H, Cantley LC (1994) Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr Biol 4:973–982
Soper GA (1907) The work of a chronic typhoid germ distributor. J Am Med Assoc 48:2019–2022
Srivastava D, Harris RC, Waters CM (2011) Integration of cyclic di-GMP and quorum sensing in the control of vpsT and aphA in Vibrio cholerae. J Bacteriol 193:6331–6341
Steigmann F, Dourdourekas D (1976) The asymptomatic HB6-Ag carrier: auto-and heterologous perils. Am J Gastroenterol 65:512–521
Strozzi GP, Mogna L (2008) Quantification of folic acid in human feces after administration of Bifidobacterium probiotic strains. J Clin Gastroenterol 42:S179–S184
Suhadolnik RJ, Baur R, Lichtenwalner DM, Uematsu T (1977) Effect of nicotinamide adenine dinucleotide analogs on template activity for DNA synthesis, incorporation into nuclear proteins, and a new 1´-3’ osidic linkage. J Biol Chem 252:4134–4144
Szostak MP, Mader H, Truppe M, Kamal M, Eko FO, Huter V, Marchart J, Jechlinger W, Haidinger W, Brand E, Denner E, Resch S, Dehlin E, Katinger A, Kuen B, Haslberger A, Hensel A, Lubitz W (1997) Bacterial ghosts as multifunctional vaccine particles. Behring Inst Mitt 98:191–196
Tack J, Depoortere I, Bisschops R, Delporte C, Coulie B, Meulemans A, Janssens J, Peeters T (2006) Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 55:327–333
Thiagarajah JR, Verkman AS (2005) New drug targets for Cholera Toxin. Trends Pharmacol Sci 26:172–175
Tolkacheva TV, Abakumov EM, Golosova TV, Volodina NI (1989) Bacteriotherapy of intestinal dysbacteriosis in patients with acute leukemia. Gematol Transfuziol 34:11–14
Toshima H, Hachio M, Ikemoto Y, Ogasawara J, Hase A, Takahashi K, Masaki H, Nishikawa Y (2007) Prevalence of enteric bacteria that inhibit growth of enterohaemorrhagic Escherichia coli O157 in humans. Epidemiol Infect 135:110–117
Toskulkao C, Rao MC (1990) Identification of a 50-kDa Ca-, cAMP-, and cGMP-dependent epithelial phosphoprotein as a cAMP regulatory protein. Am J Physiol 258:C889–C901
Tjoa WS, DuPont HL, Sullivan P, Pickering LK, Holguin AH, Olarte J, Evans DG, Evans DJ Jr (1977) Location of food consumption and travelers’ diarrhea. Am J Epidemiol 106:61–66
Trofa AF, Ueno-Olsen H, Oiwa R, Yoshikawa M (1999) Dr. Kiyoshi Shiga: discoverer of the dysentery bacillus. Clin Infect Dis 29:1303–1306
Uzunov P, Weiss B (1972) Separation of multiple molecular forms of cyclic adenosine 3′,5′-monophosphate phosphodiesterase in rat cerebellum by polyacrylamide gel electrophoresis. Biochim Biophys Acta 284:220–226
Uzzau S, Fasano A (2000) Cross-talk between enteric pathogens and the intestine. Cell Microbiol 2:83–89
Van den Berghe N, Nieuwkoop NJ, Vaandrager AB, de Jonge HR (1991) Asymmetrical distribution of G-proteins among the apical and basolateral membranes of rat enterocytes. Biochem J 278:565–571
Vandekerckhove J, Schering B, Bärmann M, Aktories K (1987) Clostridium perfringens iota toxin ADP-ribosylates skeletal muscle actin in Arg-177. FEBS Lett 225:48–52
Vanderhoof JA, Young RJ (1998) Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr 27:323–332
Wald A, Back C, Bayless TM (1976) Effect of caffeine on the human small intestine. Gastroenterology 71:738–742
Waldor MK, Mekalanos JJ (1996) Lisogenic conversion by a filamentous phage encoding cholera toxin. Science 272:1910–1914
Wang Z, Zhang L, Guo Z, Liu L, Ji J, Zhang J, Chen X, Liu B, Zhang J, Ding Q, Wang X, Zhao W, Zhu Z, Yu Y (2012) A unique feature of iron loss via close adhesion of Helicobacter pylori to host erythrocytes. PLoS ONE 7:e50314
Ward SM, Dalziel HH, Bradley ME, Buxton IL, Keef K, Westfall DP, Sanders KM (1992) Involvement of cyclic GMP in non-adrenergic, non-cholinergic inhibitory neurotransmission in dog proximal colon. Br J Pharmacol 107:1075–1082
Whitman M, Kaplan DR, Schaffhausen B, Cantley L, Roberts TM (1985) Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature 315:239–242
Whitman M, Downes CP, Keeler M, Keller T, Cantley L (1988) Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature 332:644–646
Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O’Mahony L, Kiely B, Shanahan F, Quigley EM (2006) Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 101:1581–1590
Willing BP, Vacharaksa A, Croxen M, Thanachayanont T, Finlay BB (2011) Altering host resistance to infections through microbial transplantation. PLoS ONE 6:e26988
Wolf H, Mendez M, Gilman RH, Sheen P, Soto G, Velarde AK, Zimic M, Escombe AR, Montenegro S, Oberhelman RA, Evans CA (2008) Diagnosis of pediatric pulmonary tuberculosis by stool PCR. Am J Trop Med Hyg 79:893–898
Wuensch T, Schulz S, Ullrich S, Lill N, Stelzl T, Rubio-Aliaga I, Loh G, Chamaillard M, Haller D, Daniel H (2013) The peptide transporter PEPT1 is expressed in distal colon in rodents and humans and contributes to water absorption. Am J Physiol Gastrointest Liver Physiol 305:G66–G73
Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, Gamblin SJ, Smerdon SJ, Cantley LC (1997) The structural basis for 14-3-3:phosphopeptide binding specificity.The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91:961–971
Yu H, Xu G, Fan X (2013) The effect of ghrelin on cell proliferation in small intestinal IEC-6 cells. Biomed Pharmacother 67:235–239
Zarrella TM, Singh A, Bitsaktsis C, Rahman T, Sahay B, Feustel PJ, Gosselin EJ, Sellati TJ, Hazlett KR (2011) Host-adaptation of Francisella tularensis alters the bacterium’s surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS ONE 6(7):e22335
Zhang RG, Scott DL, Westbrook ML, Nance S, Spangler BD, Shipley GG, Westbrook EM (1995) The three-dimensional crystal structure of cholera toxin. J Mol Biol 251:563–573
Ziegler M (2000) New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur J Biochem 267:1550–1564
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Villa, T.G., Feijoo-Siota, L., Rama, J.L.R., Sánchez-Pérez, A., de Miguel-Bouzas, T. (2016). Fecal Matter Implantation as a Way to Fight Diarrhea-Causing Microorganisms. In: Villa, T., Vinas, M. (eds) New Weapons to Control Bacterial Growth. Springer, Cham. https://doi.org/10.1007/978-3-319-28368-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-28368-5_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28366-1
Online ISBN: 978-3-319-28368-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)